DGAP-News

Asklepios Kliniken takes advantage of positive interest rate environment and places promissory note loan of EUR 580 million - Seite 2

promissory note loan investors also took advantage of the "amend & extend"
offer to swap their holdings. As a result, notes already issued were
converted for new securities with better conditions and longer terms.

Safeguarding flexibility with a long-term outlook

Stephan Leonhard, Deputy Chairman and CFO of the Asklepios Group,
commented: "The multiple oversubscription and the high issue volume placed
are clear evidence of the confidence shared by old and new investors alike
in our sustainable business model. The promissory note loan, with the
various innovative elements of this transaction, is a perfect fit for our
strategy of a broad mix of financing. The aim of this is to ensure
long-term security in financing coupled with flexibility and good options
for financing. In addition to cutting our average costs of capital, this
also guarantees that we have the financial leeway to implement our
corporate strategy."

Along with the traditionally conservative financing structure, one of the
main reasons given by backers for investors' willingness to subscribe and
their extreme confidence in the Asklepios Group is the secure, long-term
cash flows in particular entailed by its business model. "We are proud that
around 40% of the issue volume was subscribed by existing investors," added
Stephan Leonhard.

"With a volume of more than EUR 580 million, the Asklepios Group has
successfully concluded the biggest financing transaction in its 30-year
history, and probably the largest ever promissory note loan issue in the
hospital sector. We have therefore passed another key milestone in the
optimisation of our financing structure," said Ilmarin Schietzel, Head of
Strategic Financial Development & Capital Market Projects, of the
transaction.

The placement was managed by Bayerische Landesbank, BNP Paribas, Hessische
Landesbank and Crédit Agricole with Allen & Overy serving as legal counsel.

About Asklepios:

The healthcare group Asklepios Kliniken GmbH is one of the leading private
operators of hospitals and healthcare facilities in Germany. The hospital
group is known for highly qualified patient care with a clear commitment to
medical quality, social responsibility and innovation. The company pursues
a responsible and sustainable growth strategy geared towards high quality
and innovation. Asklepios has been performing dynamically on this basis
since it was founded 30 years ago. The Group currently has around 150
healthcare facilities throughout Germany and employs more than 45,000
people. Approximately 2.2 million patients were treated in Asklepios Group
facilities in the 2014 financial year.

Contact:

Stephan Leonhard
Deputy Chairman (CFO)
Tel.: [phone] - Fax: [phone]
[e-mail]; www.asklepios.com

Ilmarin Schietzel
Head of Strategic Financial Development & Capital Market Projects
Tel.: [phone] - Fax: [phone]
[e-mail]; www.asklepios.com



---------------------------------------------------------------------

31.08.2015 Dissemination of a Corporate News, transmitted by DGAP - a
service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de

---------------------------------------------------------------------


390569 31.08.2015